Patents by Inventor Patrick Schnider

Patrick Schnider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6747026
    Abstract: Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.
    Type: Grant
    Filed: January 7, 2003
    Date of Patent: June 8, 2004
    Assignee: Hoffman-La Roche Inc.
    Inventors: Torsten Hoffmann, Sonia Maria Poli, Patrick Schnider, Andrew Sleight
  • Publication number: 20040048901
    Abstract: Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.
    Type: Application
    Filed: August 21, 2003
    Publication date: March 11, 2004
    Inventors: Torsten Hoffmann, Sonia Maria Poli, Patrick Schnider, Andrew Sleight
  • Publication number: 20040014793
    Abstract: Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.
    Type: Application
    Filed: July 9, 2003
    Publication date: January 22, 2004
    Inventors: Torsten Hoffmann, Sonia Maria Poli, Patrick Schnider, Andrew Sleight
  • Patent number: 6642226
    Abstract: The invention relates to compounds of the formula wherein R1 is optionally substituted phenyl, morpholinyl, piperazinyl, pyrrolidinyl, piperidinyl or is thiomorpholinyl, 1-oxo-thiomorpholinyl or 1,1-dioxothiomorpholinyl. These compounds have a good affinity to the NK-1 receptor and they are therefore suitable in the control or treatment of diseases, related to this receptor.
    Type: Grant
    Filed: January 25, 2002
    Date of Patent: November 4, 2003
    Assignee: Hoffman-La Roche Inc.
    Inventors: Sabine Kolczewski, Stephan Roever, Patrick Schnider
  • Patent number: 6624176
    Abstract: The present invention is a heteroaromatic substituted amide showing antagonist activity to neurokinin 1 (NK-1, substance P) receptors.
    Type: Grant
    Filed: October 29, 2002
    Date of Patent: September 23, 2003
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Torsten Hoffmann, Patrick Schnider, Heinz Stadler
  • Publication number: 20030149039
    Abstract: Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.
    Type: Application
    Filed: January 7, 2003
    Publication date: August 7, 2003
    Inventors: Torsten Hoffmann, Sonia Maria Poli, Patrick Schnider, Andrew Sleight
  • Patent number: 6596773
    Abstract: The present invention is a series of compounds formed from phenyl substituted pyridine or benzene derivatives and their pharmaceutically acceptable salts. These compounds have shown high affinity as antagonists to the NK-1 receptor.
    Type: Grant
    Filed: January 17, 2002
    Date of Patent: July 22, 2003
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Bös, Guido Galley, Thierry Godel, Torsten Hoffmann, Walter Hunkeler, Patrick Schnider, Heinz Stadler
  • Patent number: 6593472
    Abstract: Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: July 15, 2003
    Assignee: Hoffman-La Roche Inc.
    Inventors: Torsten Hoffmann, Sonia Maria Poli, Patrick Schnider, Andrew Sleight
  • Publication number: 20030130508
    Abstract: The present invention is a heteroaromatic substituted amide showing antagonist activity to neurokinin 1 (NK-1, substance P) receptors.
    Type: Application
    Filed: October 29, 2002
    Publication date: July 10, 2003
    Inventors: Torsten Hoffmann, Patrick Schnider, Heinz Stadler
  • Patent number: 6576762
    Abstract: The present invention is a heteroaromatic substituted amide showing antagonist activity to neurokinin 1 (NK-1, substance P) receptors.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: June 10, 2003
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Torsten Hoffmann, Patrick Schnider, Heinz Stadler
  • Patent number: 6552088
    Abstract: Biphenyl substituted amides with activity as antagonists of the neurokinin 1 (NK-1, substance P) receptor.
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: April 22, 2003
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Bös, Guido Galley, Thierry Godel, Torsten Hoffmann, Walter Hunkeler, Patrick Schnider, Heinz Stadler
  • Publication number: 20030064983
    Abstract: The invention is the compounds
    Type: Application
    Filed: July 17, 2002
    Publication date: April 3, 2003
    Inventors: Theresa Maria Ballard, Torsten Hoffmann, Sonia Maria Poli, Patrick Schnider, Andrew Sleight
  • Patent number: 6479483
    Abstract: Compounds of the present invention are 4-phenyl-pyridine derivatives with activity as NK-1 receptor antagonists.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: November 12, 2002
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Bös, Quirico Branca, Guido Galley, Thierry Godel, Torsten Hoffmann, Walter Hunkeler, Patrick Schnider, Heinz Stadler
  • Publication number: 20020151547
    Abstract: The invention relates to compounds of the formula 1
    Type: Application
    Filed: January 25, 2002
    Publication date: October 17, 2002
    Inventors: Sabine Kolczewski, Stephan Roever, Patrick Schnider
  • Publication number: 20020111367
    Abstract: The present invention is a series of compounds formed from phenyl substituted pyridine or benzene derivatives and their pharmaceutically acceptable salts. These compounds have shown high affinity as antagonists to the NK-1 receptor.
    Type: Application
    Filed: January 17, 2002
    Publication date: August 15, 2002
    Inventors: Michael Bos, Guido Galley, Thierry Godel, Torsten Hoffmann, Walter Hunkeler, Patrick Schnider, Heinz Stadler
  • Publication number: 20020091265
    Abstract: The present invention relates to compounds of the general formula 1
    Type: Application
    Filed: July 10, 2001
    Publication date: July 11, 2002
    Inventors: Michael Bos, Quirico Branca, Guido Galley, Thierry Godel, Torsten Hoffmann, Walter Hunkeler, Patrick Schnider, Heinz Stadler
  • Patent number: 6407111
    Abstract: The present invention is a series of compounds formed from phenyl substituted pyridine or benzene derivatives and their pharmaceutically acceptable salts. These compounds have shown high affinity as antagonists to the NK-1 receptor.
    Type: Grant
    Filed: February 16, 2000
    Date of Patent: June 18, 2002
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Michael Bös, Guido Galley, Thierry Godel, Torsten Hoffmann, Walter Hunkeler, Patrick Schnider, Heinz Stadler
  • Publication number: 20020045642
    Abstract: Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.
    Type: Application
    Filed: July 12, 2001
    Publication date: April 18, 2002
    Inventors: Torsten Hoffmann, Sonia M. Poli, Patrick Schnider, Andrew Sleight
  • Publication number: 20020040040
    Abstract: Substituted 4-phenyl-pyridine compounds with activity as antagonists of Neurokinin 1 receptors, methods of making these compounds and preparing.
    Type: Application
    Filed: August 3, 2001
    Publication date: April 4, 2002
    Inventors: Thierry Godel, Torsten Hoffmann, Patrick Schnider, Heinz Stadler
  • Publication number: 20020040060
    Abstract: The invention relates to compounds of the formula 1
    Type: Application
    Filed: June 21, 2001
    Publication date: April 4, 2002
    Inventors: Michael Bos, Guido Galley, Thierry Godel, Torsten Hoffmann, Walter Hunkeler, Patrick Schnider, Heinz Stadler